CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in CASI Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- 0 vs. Q2 2023
- Shares held
- 344.6K
- −105.2K (−23.4%) vs. Q2 2023
- Total value
- $882.6K
- −$241.7K (−21.5%) vs. Q2 2023
- New holders
- 2
- 3 more added
- Sold out
- 2
- 7 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.66M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $920.0K |
| Q4 2023 | 18 | $1.99M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Shields Capital Management, LLC | 153,455 | $392.8K | 0.05% | −25,000−14.0% | Reduced |
| Wellington Shields & Co., LLC | 74,166 | $189.9K | 0.05% | −12,048−14.0% | Reduced |
| Vanguard Group Inc | 32,365 | $82.9K | 0.00% | −49,024−60.2% | Reduced |
| Geode Capital Management, LLC | 22,221 | $56.9K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 22,124 | $56.6K | 0.00% | −6,038−21.4% | Reduced |
| Franklin Resources Inc | 19,777 | $50.6K | 0.00% | −5,146−20.6% | Reduced |
| Renaissance Technologies LLC | 17,800 | $46.0K | 0.00% | +2,700+17.9% | Added |
| Morgan Stanley | 1,553 | $3.98K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 328 | $840 | 0.00% | +328 | New |
| Tower Research Capital LLC (TRC) | 327 | $837 | 0.00% | +123+60.3% | Added |
| BlackRock Inc. | 324 | $829 | 0.00% | −130−28.6% | Reduced |
| West Paces Advisors Inc. | 100 | $256 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 25 | $64 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 13 | $33 | 0.00% | 00.0% | Unchanged |
| Colonial Trust Co | 11 | $28 | 0.00% | 00.0% | Unchanged |
| Kozak & Associates, Inc. | 10 | $27 | 0.00% | +10 | New |
| Wells Fargo & Company | 6 | $15 | 0.00% | +1+20.0% | Added |
| Bank of America Corp | 3 | $8 | 0.00% | −658−99.5% | Reduced |
| Royal Bank of Canada | 18 | $0 | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 0 | $0 | 0.00% | −10,318−100.0% | Sold out |
| Fiduciary Alliance LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |